Germany Mammography Market Trends

The presence of a large number of diagnostic centers in the country, the increasing prevalence of breast cancer, and the presence of good healthcare infrastructure are the major factors attributing to the growth of this segment. The increasing strategic initiatives by the major players are also expected to boost the market growth. In Germany, the prevalence of breast cancer is rising gradually. In Germany, there were approximately 69,697 new instances of breast cancer reported in 2020, along with 20,579 fatalities, according to data from the International Agency for Research on Cancer. Numerous businesses run numerous programs to assist with breast cancer screenings. For instance, in and around Paderborn, Germany, Radiologie am Theater has three special breast cancer diagnostic facilities. According to the center's website, more than 15,000 breast exams are performed there annually. Two-thirds of these are screenings, which use traditional 2D mammography, while the remaining third are diagnostic mammographies, which include digital breast tomosynthesis to some extent. Such diagnostic facilities should accelerate market expansion. Mammovista B.smart, the software from Siemens Healthineers, was released in March 2021. The entire reading workflow for breast imaging can be sped up using the Mammovista B.smart software solution. The program enables transparency of key processes in the mammography examination process while finding potential bottlenecks. Such corporate releases are likely to increase the comfort of diagnostic facilities with large mammography images. This should accelerate market expansion. 

Hence, the above developments are further expected to improve the market growth in this segment.